Patent US4741357A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4103084A Expired / Lapsed US ⏱️ 0.0 years remaining

7-(Carboxy substituted α-etherified oximino arylacetamido) cephalosporins having a 3-vinyl or substituted vinyl group

Assignee: Glaxo Laboratories Ltd
•
Filing: 1976-03-19
•
Granted: 1978-07-25
•
Expires: 1996-03-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Cephalosporin antibiotics in which the 7β-acylamido group has the structure ##STR1## (where R is thienyl or furyl; R a and R b are each selected from hydrogen, C 1-4 alkyl, C 2-4 alkenyl, C 3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C 2-5 alkoxycarbonyl and cyano, or R a and R b together with the carbon atom to which they are attached form a C 3-7 cycloalkylidene or cycloalkenylidene group; and m and n are each 0 or 1 such that the sum of m and n is 0 or 1) exhibit broad spectrum antibiotic activity characterized by particularly high activity against gram negative microorganisms, including those which produce β-lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly high in vitro activity against strains of Escherichia coli, Haemophilus influenzae and Proteus organisms; compounds wherein at least one of R a and R b is other than hydrogen have also shown unusually high activity against Pseudomonas organisms. Important compounds of the above type include those in which the 7β-acylamido group is a syn-2-carboxymethoxy-2-(fur-2-yl)acetamido, syn-2-(2-carboxyprop-2-yloxyimino)-2-(fur-2-yl)acetamido or syn-2-(1-carboxycyclopent-1-yloxyimino)-2-(fur-2-yl)acetamido group.

Inventors

  • 👤 Janice Bradshaw
  • 👤 Martin Christopher Cook
  • 👤 Gordon Ian Gregory

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 20:30
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/02; C07D307/34; C07D307/38; C07D307/54; C07D333/00; C07D333/02; C07D333/04; C07D333/06; C07D333/24

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 116 words
A compound selected from the group consisting of a cephalosporin antibiotic of the formula: ##STR131## wherein R is thienyl or furyl; R a is hydrogen, methyl, ethyl, propyl, isopropyl, butyl, allyl, cyclohexyl or phenyl; R b is hydrogen, carboxy, C 2 -C 5 alkoxycarbonyl, methyl, ethyl, propyl, isopropyl, butyl, allyl, cyclohexyl or phenyl; or R a and R b together with the carbon atom to which they are attached form a cyclobutylidene, cyclopentylidene or cyclohexylidene group; and wherein R 1 and R 2 are each hydrogen, carboxy, cyano, C 2 -C 7 alkoxycarbonyl, C 1-6 alkyl, C 5-7 cycloalkyl, phenyl C 1-4 alkyl, phenyl, nitrophenyl, tolyl or naphthyl, and physiologically acceptable salt, ester or 1-oxide thereof.
Claim 2
Dependent Claim 116 words
A compound selected from the group consisting of a cephalosporin antibiotic of the formula: ##STR131## wherein R is thienyl or furyl; R a is hydrogen, methyl, ethyl, propyl, isopropyl, butyl, allyl, cyclohexyl or phenyl; R b is hydrogen, carboxy, C 2 -C 5 alkoxycarbonyl, methyl, ethyl, propyl, isopropyl, butyl, allyl, cyclohexyl or phenyl; or R a and R b together with the carbon atom to which they are attached form a cyclobutylidene, cyclopentylidene or cyclohexylidene group; and wherein R 1 and R 2 are each hydrogen, carboxy, cyano, C 2 -C 7 alkoxycarbonyl, C 1-6 alkyl, C 5-7 cycloalkyl, phenyl C 1-4 alkyl, phenyl, nitrophenyl, tolyl or naphthyl, and physiologically acceptable salt, ester or 1-oxide thereof.
Claim 3
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(2-carboxyprop-2-yloxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-methoxycarbonylvinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 4
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(1-carboxycyclopent-1-yloxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-carboxyvinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 5
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(carboxymethoxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-methoxycarbonylvinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 6
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(1-carboxycyclopent-1-yloxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-methoxycarbonylvinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 7
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-carboxymethoxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-ethoxycarbonylvinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 8
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(carboxymethoxyimino)-2-(fur-2-yl)acetamido]-3-(2-cyanovinyl)ceph-3-em-4-carboxylic acid (syn isomer).
Claim 9
Dependent Claim 11 words
The compound of claim 1 which is (6R,7R)-7-[2-(1-carboxycyclopent-1-yloxyimino)-2-(fur-2-yl)acetamido]-3-(trans-2-ethoxycarbonylvinyl)ceph-3-em-4-carboxylic acid (syn isomer).

References Cited (Backward Citations)

US3769277A Cited
DE2204060A1 Cited
DE2223375A1 Cited
US3830700A Cited
LU68680A1 Cited
BE806450R Cited
DE2262500A1 Cited
DE2460537A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-07-24 1982-01-23 1982-07-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-07-24 1986-01-23 1986-07-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-07-24 1990-01-23 1990-07-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag